Scholtz & Company’s Nutrien NTR Stock Holding History

Scholtz & Company’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,765	Closed	-$314K	–	59
2018 Q2	$314K	Buy	+5,765	New	+$286K	0.22%	48

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $13.6B AUM 17.82% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Scholtz & Company's NTR Position: Q3 2018 in Review

Scholtz & Company sold out of Nutrien (NTR) in Q3 2018, closing a stake of 5,765 shares — an estimated $314K sold.

Scholtz & Company first reported a position in NTR in Q2 2018 and held it in 1 quarter. The position peaked at $314K in Q2 2018. 597 funds tracked by Wall St. Rank hold NTR as of Q3 2018.

Scholtz & Company reported no remaining Nutrien position as of Q3 2018 after selling out during the quarter.
Scholtz & Company sold 5,765 Nutrien shares in Q3 2018, an estimated $314K.
Scholtz & Company first reported a position in Nutrien in Q2 2018 and held it in 1 quarter.
Scholtz & Company's Nutrien position peaked at $314K in Q2 2018.
597 funds tracked by Wall St. Rank held Nutrien as of Q3 2018.

Based on Scholtz & Company's 13F filing for Q3 2018, filed 14 Nov 2018.